Amanote Research
Register
Sign In
A New Class of Safe Oligosaccharide Polymer Therapy to Modify the Mucus Barrier of Chronic Respiratory Disease
doi 10.1021/acs.molpharmaceut.5b00794.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
A New Class of Safe Oligosaccharide Polymer Therapy to Modify the Mucus Barrier of Chronic Respiratory Disease
The Epidemiology of Chronic Respiratory Disease
Preventive Medicine
Epidemiology
Public Health
Occupational Health
Environmental
Barrier Function of Gastric Mucus.
Keio Journal of Medicine
Medicine
The Presence of Chronic Mucus Hypersecretion Across Adult Life in Relation to Chronic Obstructive Pulmonary Disease Development
American Journal of Respiratory and Critical Care Medicine
Pulmonary
Critical Care
Respiratory Medicine
Intensive Care Medicine
New Drugs: Respiratory and Allergic Disease. II. Chronic Obstructive Airways Disease and Respiratory Infections
BMJ
Nanoparticles Decorated With Proteolytic Enzymes, a Promising Strategy to Overcome the Mucus Barrier
European Journal of Pharmaceutics and Biopharmaceutics
Medicine
Biotechnology
Pharmaceutical Science
A Barrier Certificate Approach to the Verification of the Safe Operation of a Chemical Reactor
IFAC Proceedings Volumes
Benefits of Respiratory Muscle Stretch Gymnastics in Chronic Respiratory Disease
The Showa University Journal of Medical Sciences
Have Chronic Respiratory Disease, Will Travel?
Lancet Respiratory Medicine,The
Pulmonary
Respiratory Medicine
